Ultragenyx (RARE) Fundamental Analysis: Revenue, Earnings & Valuation

1.60 / 10

Underperform

Fundamental rating is Underperform with a 1.6/10 score. Profit‑MV and Cash‑MV are modestly bullish, but Asset‑MV and Revenue‑MV are weak. Margins and turnover ratios offer limited upside, suggesting a defensive, low‑growth profile.

Analysis Checks(6/10)

Revenue-MV

Value-0.28

Score1/3

Weight22.09%

1M Return5.44%

Inventory turnover ratio

Value2.25

Score2/3

Weight-1.63%

1M Return-0.56%

Gross profit margin (%)

Value83.80

Score0/3

Weight-12.85%

1M Return-5.42%

Profit-MV

Value0.68

Score2/3

Weight25.22%

1M Return6.36%

Income tax / Total profit (%)

Value-0.70

Score2/3

Weight3.17%

1M Return0.98%

Current assets turnover ratio

Value0.76

Score1/3

Weight-0.55%

1M Return-0.17%

Fixed assets turnover ratio

Value2.64

Score2/3

Weight0.03%

1M Return0.01%

Cost of sales ratio (%)

Value16.20

Score2/3

Weight-10.34%

1M Return-3.62%

Asset-MV

Value-0.55

Score1/3

Weight50.16%

1M Return11.48%

Cash-MV

Value0.03

Score2/3

Weight24.71%

1M Return6.19%

Is RARE fundamentally strong?

RARE scores 1.60/10 on fundamentals and holds a Premium valuation at present. Backed by its -608.47% ROE, -85.44% net margin, -3.24 P/E ratio, -25.55 P/B ratio, and 7.31% earnings growth, these metrics solidify its Underperform investment rating.